In breast cancer specimens, CD34 expression is reduced and SMA expression is increased within the stroma of high grade ductal carcinoma in situ [63,64], which may reflect differentiation of fibrocytes within the developing tumor stroma. The gene discussed is CD34; the disease is breast cancer.